Zacks: Brokerages Expect Xylem Inc (XYL) Will Post Quarterly Sales of $1.18 Billion

Wall Street analysts forecast that Xylem Inc (NYSE:XYL) will report $1.18 billion in sales for the current fiscal quarter, according to Zacks. Six analysts have made estimates for Xylem’s earnings, with the highest sales estimate coming in at $1.22 billion and the lowest estimate coming in at $1.15 billion. Xylem posted sales of $1.07 billion during the same quarter last year, which would indicate a positive year over year growth rate of 10.3%. The business is scheduled to announce its next quarterly earnings results on Tuesday, May 1st.

On average, analysts expect that Xylem will report full year sales of $1.18 billion for the current fiscal year, with estimates ranging from $4.97 billion to $5.25 billion. For the next financial year, analysts expect that the business will post sales of $5.40 billion per share, with estimates ranging from $5.19 billion to $5.54 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Xylem.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.76 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.76. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.66 EPS.

A number of brokerages recently issued reports on XYL. Oppenheimer increased their price objective on Xylem to $82.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Seaport Global Securities restated a “buy” rating and issued a $83.00 target price on shares of Xylem in a research note on Friday, February 2nd. BMO Capital Markets restated a “buy” rating and issued a $86.00 target price on shares of Xylem in a research note on Friday, February 2nd. Canaccord Genuity restated a “hold” rating and issued a $75.00 target price on shares of Xylem in a research note on Sunday, January 28th. Finally, Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 13th. Six investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $70.08.

Shares of Xylem (NYSE:XYL) traded up $0.52 on Friday, reaching $75.23. The company had a trading volume of 956,262 shares, compared to its average volume of 1,160,000. The stock has a market cap of $13,510.00, a PE ratio of 41.11, a price-to-earnings-growth ratio of 1.44 and a beta of 1.20. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.88 and a quick ratio of 1.41. Xylem has a twelve month low of $46.95 and a twelve month high of $76.81.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Thursday, February 15th will be paid a $0.21 dividend. This is a positive change from Xylem’s previous quarterly dividend of $0.18. This represents a $0.84 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Wednesday, February 14th. Xylem’s dividend payout ratio is currently 45.90%.

In other news, insider Tomas Brannemo sold 2,260 shares of the stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $67.75, for a total transaction of $153,115.00. Following the transaction, the insider now directly owns 10,975 shares in the company, valued at approximately $743,556.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven R. Loranger sold 17,139 shares of the stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $68.10, for a total value of $1,167,165.90. Following the transaction, the director now owns 26,150 shares in the company, valued at $1,780,815. The disclosure for this sale can be found here. Insiders sold a total of 75,455 shares of company stock worth $5,166,873 over the last 90 days. Corporate insiders own 0.75% of the company’s stock.

Several institutional investors have recently made changes to their positions in XYL. BlackRock Inc. increased its position in shares of Xylem by 16.0% during the 4th quarter. BlackRock Inc. now owns 14,130,060 shares of the industrial products company’s stock valued at $963,668,000 after purchasing an additional 1,949,335 shares during the last quarter. Eaton Vance Management increased its position in shares of Xylem by 5,143.0% during the 4th quarter. Eaton Vance Management now owns 772,562 shares of the industrial products company’s stock valued at $52,688,000 after purchasing an additional 757,827 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Xylem by 31.6% during the 3rd quarter. Bank of New York Mellon Corp now owns 2,027,810 shares of the industrial products company’s stock valued at $127,002,000 after purchasing an additional 487,360 shares during the last quarter. Amundi Pioneer Asset Management Inc. increased its position in shares of Xylem by 180.3% during the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 734,057 shares of the industrial products company’s stock valued at $50,063,000 after purchasing an additional 472,188 shares during the last quarter. Finally, TD Asset Management Inc. increased its position in shares of Xylem by 47.7% during the 3rd quarter. TD Asset Management Inc. now owns 1,222,128 shares of the industrial products company’s stock valued at $76,542,000 after purchasing an additional 394,814 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Zacks: Brokerages Expect Xylem Inc (XYL) Will Post Quarterly Sales of $1.18 Billion” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/02/19/zacks-brokerages-expect-xylem-inc-xyl-will-post-quarterly-sales-of-1-18-billion.html.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply